Mechanism-centric regulatory network identifies NME2 and MYC programs as markers of Enzalutamide resistance in CRPC von Panja, Sukanya, Truica, Mihai Ioan, Yu, Christina Y., Saggurthi, Vamshi, Craige, Michael W., Whitehead, Katie, Tuiche, Mayra V., Al-Saadi, Aymen, Vyas, Riddhi, Ganesan, Shridar, Gohel, Suril, Coffman, Frederick, Parrott, James S., Quan, Songhua, Jha, Shantenu, Kim, Isaac, Schaeffer, Edward, Kothari, Vishal, Abdulkadir, Sarki A., Mitrofanova, Antonina

Volltext